At Kappa Bioscience we are proud to offer you high purity vitamin K2 as menaquinone-7 (MK-7). As the innovative leader and first mover of vitamin K2 MK-7, we have extensive knowledge about vitamins and are currently the only vendor with vitamin K2 as pure MK-7 in various formulations. Based on the self-affirmed GRAS approval, our K2 MK-7 can also be used in conventional foods.
Founded in December 2006, Kappa Bioscience is a Norwegian based entity that takes pride in following a traditional vitamin production process with propriety and innovative new steps. One of our core assets is the patent covering the production of pure vitamin K2 as menaquinone‑7.
Our main focus is to develop vitamin K2 for the food supplement and fortified foods market.
Vitamin K2 is currently gaining momentum across the world and as it does, we intend to continue to serve the market with pure and stable forms of MK-7 products.
All of our products have been developed in close collaboration with highly qualified Norwegian and international scientists, who have been able to successfully accomplish the difficult process of producing menaquinone-7.
We are proud to launch the first man-made menaquinone-7 in its natural form - as K2VITAL®.
- Our research is conducted globally
- Production is established in Europe
- Marketing and sales activities are managed from Germany.
Kappa Bioscience has the vision to making vitamin K2 available to everybody, everywhere.
We believe our product – Vitamin K2 MK-7 and our mission is to provide everyone from manufacturers to consumers with a pure, reliable and safe product. We take pride in delivering everyone with a quality product for improving health.
The company values shall guide each individual employee’s behavior and be the basis for creating a transparent and collaborative company culture. Kappa Bioscience’s core values are:
Bravery / Openness / Activeness
We are committed to educating the industry about the many benefits of vitamin K2 MK-7 for health. Read our latest presence in the media below:
- Vitamin K2
President and CEO
Egil is an entrepreneur with broad executive experience from building up companies and business units within the multinational companies Norsk Hydro ASA, Yara International ASA and AKZO Nobel. He also headed several SMBs including NattoPharma ASA before he was asked to build up Kappa Bioscience in 2009.
VP Finance & Operations
MSc (Management & Economics), INSEAD EMP
Kai is an executive with experience from international companies such as GE Healthcare, Philip Morris International and Porsche in functions ranging from Manufacturing & Supply Chain to General Management. He accumulated extensive know-how in the areas of Managing P&Ls, Commercial Management and Leadership, Finance and Strategy as well as Sales & Operations Planning.
VP Science & Product Development
Trygve has a broad experience in research and documentation within the nutraceutical and pharmaceutical industry. Before joining Kappa Bioscience, Trygve was responsible for the clinical documentation program in Aker BioMarine. He has generated extensive experience from management of clinical research in Clavis Pharma and LINK Medical Research.
Inger Reidun F. Aukrust
Vice President R&D & Chemistry
PhD in Organic Chemistry
More than 25 years of experience within medicinal chemistry and custom synthesis from SINTEF and Synthetica. Founder of Synthetica and Kappa Bioscience.
Vice President Sales
Jörg is responsible for the groups global sales and marketing organization. He has been a member of the nutraceutical industry for more than 15 years, during which time he was involved in the introduction of several successful specialities including PressCAL®, AlgaeCal®, NEM®, Calcified Atlantic Seaweed® and K2VITAL®.
Jon Erik Brænden
Vice President Production
Jon Erik is responsible for the production, and holds a PhD in organic chemistry. Before joining Kappa Bioscience he has been 25 years in the pharmaceutical industry, responsible for documentation, product and process development of active pharmaceutical ingredients, within the area of contrast agents, cancer, analgesics (opioids) and diabetes.
Vice President Quality & Regulatory
Master in Food Science & Technology
Henriette is responsible of the global quality management and regulatory affairs. She holds a Master’s degree and worked for global companies such as Colgate-Palmolive, Mondelez International, Chr Hansen and Kevin Murphy. She gained a broad experience in developing and implementing regulatory strategies, evaluating the compliance of product content, specifications, labeling and registrations and quality management.
Vice President Marketing
MSc in Food Chemistry
Dominik is a leader with 20 years of progressive experience in the nutraceutical industry and is spearheading marketing at Kappa Bioscience. Dominik is known for his pioneering approach to commercial models and product innovation. Passionate for business ethics and sustainability, he is a staunch supporter of the triple-bottom-line: people-planet-profit. Before Kappa, Dominik has served in international companies such as SwissCaps, Capsugel and Lonza.
The origin of K2VITAL® dates back to 2006, when Norwegian researcher, Dr Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans Vitamin K2, MK-7, using natural compounds such as geraniol and farnesol in a strictly controlled synthesis process.
The significance of the process for all-trans vitamin K2 MK-7 has been recognised and patented. For vitamin K’s, two stereo chemical versions can exist: cis and trans forms of the molecule. The cis form remains biologically inactive, while the trans form has a full biological potential. Commercially available vitamin K2 products may contain both forms.
Kappa is proud to work and collaborate with the leading nutritional supplements distributors in regions that span the globe. We invite you to contact our distributors directly to learn about K2VITAL® and the Kappa product portfolio, or contact Kappa directly and we will make an introduction.
|Distributor||Country||Regio||Operative in charge|
|Pathway||Australia and New Zealand||Asia||Mr Wayne Coote (Email)|
|SA Pharmachem||India||Asia||Ms Mayuri Musham (Email)|
|Connell||Bangladesh||Asia||Ms Saadia Aleema Hoque (Email)|
|Vietnam||Asia||Ms. Thi (Pharma) (Email)|
Ms. Phoi (Food) (Email)
|Epic Ingredients||Malaysia||Asia||Mr Jeffrey Aw (Email)|
|Connell Bros||Taiwan||Asia||Ms Irene Hsueh (Email)|
|Phytonet||Philippines||Asia||Mrs Helen Grace Basia (Email)|
Mr Ali Hassni (Email)
|Phytonet||Korea||Asia||Mr Allen Lee (Email)|
|Rama Production||Thailand||Asia||Ms Prakaithip Ekwongsupasarn (Email)|
Shanghai Toong Yeuan Food Tech Ltd.
|China||Asia||Steven Wang (Email)|
|PT Tatarasa||Indonesia||Asia||Mr Soekiandi Ali (Email)|
|Zifroni Chemicals||Israel||Middle East||Rafi Zifroni (Email)|
|TFS Group||Russia||Europe/ Asia||Ilya Okhotin (Email)|
|Faravelli||Italy||Europe||Tiziana Ferrari (Email)|
|KUK||Eastern Europe||Europe||Stephan Wohlrab (Email)|
|Phytonet||Turkey||Europe||Selim Ay (Email)|
|VITA NOVA-ZA||Balkan||Europe||Zagorka Blazevska (Email)|
|Safic Alcan||Spain||Europe||Mercedes Carillo (Email)|
|Safic Alcan||France + Morocco||Europe||Charlotte Delarue (Email)|
|KUK||Baltic + Greece||Europe||Līga Eglīte (Email)|
|Solo Group||South Africa||Africa||Dean Hall (Email)|
|Biochimex||Algeria + Tunisia||Africa||Christielle Dupain (Email)|
|AIDP||USA||America||Mark Thurston (Email)|
|RJR Nutrientes e Farmoquímicos Ltda.||Brazil||America||Felipe Simões (Email)|
|Safe Iberoamericana S.A. de C.V.||Mexico||America||Jorge Cabeiro (Email)|
|Deltagen SAS.||Colombia||America||Paul Agudelo (Email)|